Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 5.65 million shares were traded. GERN stock price reached its highest trading level at $1.36 during the session, while it also had its lowest trading level at $1.305.
Ratios:
For a deeper understanding of Geron Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.87 and its Current Ratio is at 5.96. In the meantime, Its Debt-to-Equity ratio is 1.01 whereas as Long-Term Debt/Eq ratio is at 0.93.
On May 08, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $1.50.
B. Riley Securities Downgraded its Buy to Neutral on February 27, 2025, whereas the target price for the stock was revised from $3.50 to $2.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 15 ’25 when JAMES ZIEGLER bought 20,000 shares for $1.37 per share.
LAWLIS V BRYAN bought 13,300 shares of GERN for $15,667 on May 09 ’25. The Director now owns 13,300 shares after completing the transaction at $1.18 per share. On Feb 27 ’25, another insider, Samuels Scott Alan, who serves as the EVP, Chief Legal Officer of the company, bought 15,000 shares for $1.61 each. As a result, the insider paid 24,150 and bolstered with 26,682 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 842628992 and an Enterprise Value of 584012992. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.59 while its Price-to-Book (P/B) ratio in mrq is 3.39. Its current Enterprise Value per Revenue stands at 3.184 whereas that against EBITDA is -9.334.
Stock Price History:
The Beta on a monthly basis for GERN is 0.59, which has changed by -0.61516035 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $3.68, while it has fallen to a 52-week low of $1.04. The 50-Day Moving Average of the stock is 6.33%, while the 200-Day Moving Average is calculated to be -2.23%.
Shares Statistics:
For the past three months, GERN has traded an average of 7.67M shares per day and 5352380 over the past ten days. A total of 638.36M shares are outstanding, with a floating share count of 607.30M. Insiders hold about 4.87% of the company’s shares, while institutions hold 75.45% stake in the company. Shares short for GERN as of 1765756800 were 76015555 with a Short Ratio of 9.91, compared to 1763078400 on 77603709. Therefore, it implies a Short% of Shares Outstanding of 76015555 and a Short% of Float of 12.45.
Earnings Estimates
At present, 2.0 analysts are actively evaluating the performance of Geron Corp (GERN) in the stock market.The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.12 and -$0.12 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is -$0.02, with 2.0 analysts recommending between -$0.01 and -$0.03.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $50.88M this quarter.It ranges from a high estimate of $51.97M to a low estimate of $49.2M. As of. The current estimate, Geron Corp’s year-ago sales were $47.54MFor the next quarter, 6 analysts are estimating revenue of $53.85M. There is a high estimate of $57.31M for the next quarter, whereas the lowest estimate is $48.7M.
A total of 6 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $187.84M, while the lowest revenue estimate was $185.1M, resulting in an average revenue estimate of $186.76M. In the same quarter a year ago, actual revenue was $76.99MBased on 6 analysts’ estimates, the company’s revenue will be $260.39M in the next fiscal year. The high estimate is $292.8M and the low estimate is $235.31M.
